These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3679 related articles for article (PubMed ID: 23873081)

  • 1. DNA targeting specificity of RNA-guided Cas9 nucleases.
    Hsu PD; Scott DA; Weinstein JA; Ran FA; Konermann S; Agarwala V; Li Y; Fine EJ; Wu X; Shalem O; Cradick TJ; Marraffini LA; Bao G; Zhang F
    Nat Biotechnol; 2013 Sep; 31(9):827-32. PubMed ID: 23873081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects.
    Kleinstiver BP; Pattanayak V; Prew MS; Tsai SQ; Nguyen NT; Zheng Z; Joung JK
    Nature; 2016 Jan; 529(7587):490-5. PubMed ID: 26735016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences.
    Lin Y; Cradick TJ; Brown MT; Deshmukh H; Ranjan P; Sarode N; Wile BM; Vertino PM; Stewart FJ; Bao G
    Nucleic Acids Res; 2014 Jun; 42(11):7473-85. PubMed ID: 24838573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity.
    Pattanayak V; Lin S; Guilinger JP; Ma E; Doudna JA; Liu DR
    Nat Biotechnol; 2013 Sep; 31(9):839-43. PubMed ID: 23934178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationally engineered Cas9 nucleases with improved specificity.
    Slaymaker IM; Gao L; Zetsche B; Scott DA; Yan WX; Zhang F
    Science; 2016 Jan; 351(6268):84-8. PubMed ID: 26628643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolved Cas9 variants with broad PAM compatibility and high DNA specificity.
    Hu JH; Miller SM; Geurts MH; Tang W; Chen L; Sun N; Zeina CM; Gao X; Rees HA; Lin Z; Liu DR
    Nature; 2018 Apr; 556(7699):57-63. PubMed ID: 29512652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crossing enhanced and high fidelity SpCas9 nucleases to optimize specificity and cleavage.
    Kulcsár PI; Tálas A; Huszár K; Ligeti Z; Tóth E; Weinhardt N; Fodor E; Welker E
    Genome Biol; 2017 Oct; 18(1):190. PubMed ID: 28985763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease.
    Cho SW; Kim S; Kim JM; Kim JS
    Nat Biotechnol; 2013 Mar; 31(3):230-2. PubMed ID: 23360966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perfectly matched 20-nucleotide guide RNA sequences enable robust genome editing using high-fidelity SpCas9 nucleases.
    Zhang D; Zhang H; Li T; Chen K; Qiu JL; Gao C
    Genome Biol; 2017 Oct; 18(1):191. PubMed ID: 29020979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity.
    Ran FA; Hsu PD; Lin CY; Gootenberg JS; Konermann S; Trevino AE; Scott DA; Inoue A; Matoba S; Zhang Y; Zhang F
    Cell; 2013 Sep; 154(6):1380-9. PubMed ID: 23992846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Origins of Programmable Nucleases for Genome Engineering.
    Chandrasegaran S; Carroll D
    J Mol Biol; 2016 Feb; 428(5 Pt B):963-89. PubMed ID: 26506267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiplex genome engineering using CRISPR/Cas systems.
    Cong L; Ran FA; Cox D; Lin S; Barretto R; Habib N; Hsu PD; Wu X; Jiang W; Marraffini LA; Zhang F
    Science; 2013 Feb; 339(6121):819-23. PubMed ID: 23287718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering.
    Mali P; Aach J; Stranges PB; Esvelt KM; Moosburner M; Kosuri S; Yang L; Church GM
    Nat Biotechnol; 2013 Sep; 31(9):833-8. PubMed ID: 23907171
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Acharya S; Mishra A; Paul D; Ansari AH; Azhar M; Kumar M; Rauthan R; Sharma N; Aich M; Sinha D; Sharma S; Jain S; Ray A; Jain S; Ramalingam S; Maiti S; Chakraborty D
    Proc Natl Acad Sci U S A; 2019 Oct; 116(42):20959-20968. PubMed ID: 31570623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome engineering using the CRISPR-Cas9 system.
    Ran FA; Hsu PD; Wright J; Agarwala V; Scott DA; Zhang F
    Nat Protoc; 2013 Nov; 8(11):2281-2308. PubMed ID: 24157548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases.
    Cho SW; Kim S; Kim Y; Kweon J; Kim HS; Bae S; Kim JS
    Genome Res; 2014 Jan; 24(1):132-41. PubMed ID: 24253446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis.
    Hou Z; Zhang Y; Propson NE; Howden SE; Chu LF; Sontheimer EJ; Thomson JA
    Proc Natl Acad Sci U S A; 2013 Sep; 110(39):15644-9. PubMed ID: 23940360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineered CRISPR-Cas9 nucleases with altered PAM specificities.
    Kleinstiver BP; Prew MS; Tsai SQ; Topkar VV; Nguyen NT; Zheng Z; Gonzales AP; Li Z; Peterson RT; Yeh JR; Aryee MJ; Joung JK
    Nature; 2015 Jul; 523(7561):481-5. PubMed ID: 26098369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cpf1 nucleases demonstrate robust activity to induce DNA modification by exploiting homology directed repair pathways in mammalian cells.
    Tóth E; Weinhardt N; Bencsura P; Huszár K; Kulcsár PI; Tálas A; Fodor E; Welker E
    Biol Direct; 2016 Sep; 11():46. PubMed ID: 27630115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas9 searches for a protospacer adjacent motif by lateral diffusion.
    Globyte V; Lee SH; Bae T; Kim JS; Joo C
    EMBO J; 2019 Feb; 38(4):. PubMed ID: 30573670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 184.